VTI-1002

N/A

Report date: 2024/11/25 15:29:40
NME

Base Information

Drug NameVTI-1002
Drug Alias NameVTI-1002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGranzyme B inhibitors
TargetsGranzyme B
Therapy Area/IndicationsEpidermolysis Bullosa Acquisita
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesviDA Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of British Columbia
Active IndicationsN/A
Inactive IndicationsEpidermolysis Bullosa Acquisita

Other Information

ATC CodeN/A
Related LinksN/A